Ignite Creation Date:
2025-12-25 @ 4:03 AM
Ignite Modification Date:
2026-01-11 @ 4:32 PM
Study NCT ID:
NCT00259402
Status:
COMPLETED
Last Update Posted:
2009-12-07
First Post:
2005-11-28
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Oxaliplatin in Esophagus Cancer (Advanced) 1st Line
Sponsor:
Sanofi
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EFC_7127
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Medical Affairs Study Director
Old Organization:
sanofi-aventis